• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Probiotics for the Treatment of Gastric Diseases
Nutr Cancer. 2022 Apr 20:1-7. doi: 10.1080/01635581.2022.2067335. Online ahead of print.ABSTRACTCommon gastric diseases include chronic gastritis, gastric ulcers and gastric cancer. The etiology of gastric diseases is complicated, including genetics, diet, excessive smoking and drinking, environmental factors, and bacterial infections. As live microorganisms, probiotics can confer health benefits to the host. At present, probiotics have been widely used in the preparation of foods, health products, and medicines. Due to their positive effects in improving diarrhea, constipation, alleviating allergies, enhancing immunity, a...
Source: Nutrition and Cancer - April 20, 2022 Category: Cancer & Oncology Authors: Yingying Xing Xinyue Gu Guojing Ruan Simiao Chen Source Type: research

The Association between the Preservative Agents in Foods and the Risk of Breast Cancer.
Abstract In the etiology of breast malignancy, dietary habits and lifestyle-related risk factors in the coherence of cancer prevention guidelines, e.g., WCRF/AICR is well documented. In addition, the consumption of staple food products rich in carbohydrate as major calorie resources such as potato, bread, and ready-to-eat cereals are partly object to having roles in breast tumorigenesis. In this review, the possible associations of preservatives and nutritive risk factors of staple foods in dietary patterns with breast cancer development based on the experimental and observational cohort-based studies were discuss...
Source: Nutrition and Cancer - May 1, 2019 Category: Cancer & Oncology Authors: Javanmardi F, Rahmani J, Ghiasi F, Hashemi Gahruie H, Mousavi Khaneghah A Tags: Nutr Cancer Source Type: research

First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer
Conclusion: To the best of our knowledge, this is the first report of nivolumab-induced CRS in a patient with gastric cancer.Case Rep Oncol 2019;12:147 –156
Source: Case Reports in Oncology - February 8, 2019 Category: Cancer & Oncology Source Type: research

A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk
ConclusionsSpecific multimorbidities aggregate and associate with PDAC in a time-dependent manner. A better characterization of a high-risk population for PDAC may help in the early diagnosis of this cancer. The common genetic basis between MP and PDAC points to a mechanistic link between these conditions.
Source: Annals of Oncology - April 5, 2017 Category: Cancer & Oncology Source Type: research

Epigenetic silencing of BTB and CNC homology 2 and concerted promoter CpG methylation in gastric cancer
In this study, restriction landmark genomic scanning revealed methylation at a NotI site in a CpG island covering the BACH2 promoter in gastric cancer cell lines and primary gastric tumors. Increased methylation of the BACH2 promoter was observed in 52% (43/83) of primary gastric tumors, and BACH2 hypermethylation was significantly associated with decreased gene expression. Treatment with 5-aza-2′-deoxycytidine and/or trichostatin. A restored BACH2 expression in BACH2-silenced gastric cancer cell lines, and knockdown of BACH2 using short hairpin RNA (i.e. RNA interference) increased cell proliferation in gastric cancer c...
Source: Cancer Letters - June 9, 2014 Category: Cancer & Oncology Authors: Keeok Haam, Hee-Jin Kim, Kyung-Tae Lee, Jeong-Hwan Kim, Mirang Kim, Seon-Young Kim, Seung-Moo Noh, Kyu-Sang Song, Yong Sung Kim Tags: Research Articles Source Type: research